e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Chronic airway disease: markers of disease impact
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adult bronchiectasis patients: microbiological insight in the Moldovan Bronchiectasis Registry
O. Munteanu (Chisihau, Republic of Moldova)
Source:
International Congress 2017 – Chronic airway disease: markers of disease impact
Session:
Chronic airway disease: markers of disease impact
Session type:
Thematic Poster
Number:
4016
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Munteanu (Chisihau, Republic of Moldova). Adult bronchiectasis patients: microbiological insight in the Moldovan Bronchiectasis Registry. 4016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018
Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Etiology and outcome of bronchiectasis in children
Source: International Congress 2014 – Paediatric bronchology
Year: 2014
Haemoptysis amongst Asian Non-Cystic Fibrosis Bronchiectasis patients: a unique phenotype
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Exacerbations and pneumonia in bronchiectasis: Clinical and microbiological characterization
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies?
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Microbiota in children with HIV-associated bronchiectasis
Source: International Congress 2016 – Paediatric respiratory infection and immunology
Year: 2016
Microbial aetiology and outcomes of CAP in bronchiectatic patients
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
Nontuberculous mycobacteria in patients with bronchiectasis: data from the German Bronchiectasis Registry PROGNOSIS
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
New isolation of non-tuberculous mycobacteria in patients with bronchiectasis - data from the European Bronchiectasis Registry (EMBARC)
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016
Asthma diagnosis in children with community-acquired pneumonia: New challenges
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
Clinico-pathological profile of adult bronchiectasis patients at a North Indian teaching hospital
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Is pulmonary sarcoidosis more severe in children? A multicentric retrospective study
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Diagnosis of asthma in children: findings from the Swiss Paediatric Airway Cohort
Source: Virtual Congress 2020 – Hot topics in paediatric asthma
Year: 2020
Diagnosis of asthma in children: findings from the Swiss Paediatric Airway Cohort
Source: Eur Respir J, 56 (5) 2000132; 10.1183/13993003.00132-2020
Year: 2020
The evaluation of epidemiological data and etiological reasons of bronchiectasis patients
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept